1. Home
  2. PACK vs PRTC Comparison

PACK vs PRTC Comparison

Compare PACK & PRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ranpak Holdings Corp

PACK

Ranpak Holdings Corp

HOLD

Current Price

$3.75

Market Cap

303.3M

ML Signal

HOLD

Logo PureTech Health plc

PRTC

PureTech Health plc

HOLD

Current Price

$17.61

Market Cap

400.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PACK
PRTC
Founded
1972
2015
Country
United States
United States
Employees
N/A
90
Industry
Containers/Packaging
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
303.3M
400.2M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
PACK
PRTC
Price
$3.75
$17.61
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$6.50
N/A
AVG Volume (30 Days)
338.1K
3.2K
Earning Date
05-05-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$395,000,000.00
N/A
Revenue This Year
$9.29
N/A
Revenue Next Year
$8.35
N/A
P/E Ratio
N/A
$8.09
Revenue Growth
7.08
N/A
52 Week Low
$2.91
$14.50
52 Week High
$6.31
$19.92

Technical Indicators

Market Signals
Indicator
PACK
PRTC
Relative Strength Index (RSI) 47.42 66.42
Support Level $3.36 $16.60
Resistance Level $3.79 $18.12
Average True Range (ATR) 0.16 0.40
MACD 0.09 0.34
Stochastic Oscillator 71.03 87.31

Price Performance

Historical Comparison
PACK
PRTC

About PACK Ranpak Holdings Corp

Ranpak Holdings Corp is a provider of environmentally sustainable, systems-based, product protection solutions for e-Commerce and industrial supply chains. The company offers a full suite of protective packaging systems and paper consumables. The group generates revenue by providing its PPS systems and paper consumables to customers, which include direct end-users and a network of exclusive paper packaging solution distributors, and by providing end-of-line automation systems that solve challenges, including optimization, customization, and efficiency. It has two segments, North America and Europe/Asia.

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

Share on Social Networks: